Trinity Biotech PLC
NASDAQ:TRIB
Trinity Biotech PLC
Income from Continuing Operations
Trinity Biotech PLC
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Trinity Biotech PLC
NASDAQ:TRIB
|
Income from Continuing Operations
-$36.9m
|
CAGR 3-Years
-83%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Medtronic PLC
NYSE:MDT
|
Income from Continuing Operations
$4.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
STERIS plc
NYSE:STE
|
Income from Continuing Operations
$553.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
16%
|
See Also
What is Trinity Biotech PLC's Income from Continuing Operations?
Income from Continuing Operations
-36.9m
USD
Based on the financial report for Dec 31, 2023, Trinity Biotech PLC's Income from Continuing Operations amounts to -36.9m USD.
What is Trinity Biotech PLC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-10%
Over the last year, the Income from Continuing Operations growth was 10%. The average annual Income from Continuing Operations growth rates for Trinity Biotech PLC have been -83% over the past three years , -10% over the past five years .